Hodgkin's lymphoma in children - Mahjoub, Najet;Ben Mansour, Hajer;Chraiet, Nesrine
29,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
15 °P sammeln
  • Broschiertes Buch

Hodgkin's disease (HD) accounts for 6% of childhood tumors. A disease of older children and adolescents, it is quite exceptional before the age of 2, and its frequency increases with age. The prognosis for MDH has improved considerably in recent decades. In developed countries, long-term survival has risen from 40% in the 60s to over 90% in the 90s, making this hemopathy a model of success in pediatric oncology. These results have been achieved thanks to the identification of prognostic factors that have enabled therapeutic protocols to be adapted.

Andere Kunden interessierten sich auch für
Produktbeschreibung
Hodgkin's disease (HD) accounts for 6% of childhood tumors. A disease of older children and adolescents, it is quite exceptional before the age of 2, and its frequency increases with age. The prognosis for MDH has improved considerably in recent decades. In developed countries, long-term survival has risen from 40% in the 60s to over 90% in the 90s, making this hemopathy a model of success in pediatric oncology. These results have been achieved thanks to the identification of prognostic factors that have enabled therapeutic protocols to be adapted.
Autorenporträt
Professora Nesrine ChraietProfessora de Oncologia Médica. Centro Nacional do Cancro Salah Azaiez, Tunis (ISA)Coordenadora do CEC de Oncologia Pediátrica, Faculdade de Medicina de TunesProfessor Ag Najet MahjoubChefe do Departamento de Oncologia Médica do Centro Anti-Cancro de JendoubaDr. Hajer Ben MansourMédico oncologista no centro de cancro do ISA.